These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21844873)

  • 1. Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission.
    Chou WC; Peng KY; Lei WC; Ko BS; Tsay W; Kuo CH; Tien HF
    Leukemia; 2012 Mar; 26(3):527-9. PubMed ID: 21844873
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission.
    Takahashi K; Roh W; Zhang J; Propotopov A; Patel K; Strickland S; Kim A; Vnencak-Jones C; Pelletier S; Parmar S; Garcia-Manero G; Kornblau S; Chin L; Kantarjian H; Futreal PA; Ravandi F
    Am J Hematol; 2015 Jul; 90(7):E134-5. PubMed ID: 25801490
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of mutant IDH1 in acute myeloid leukaemia.
    Yaqub F
    Lancet Oncol; 2015 Jan; 16(1):e9. PubMed ID: 25638561
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on NPM1 and IDH mutations in childhood acute myeloid leukemia].
    Zhang L; Zeng HM; Ai XF
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):449-52. PubMed ID: 23688760
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic targeting of isocitrate dehydrogenase mutant AML.
    Boddu P; Borthakur G
    Expert Opin Investig Drugs; 2017 May; 26(5):525-530. PubMed ID: 28388242
    [No Abstract]   [Full Text] [Related]  

  • 6. Nucleophosmin gene mutation in acute myeloid leukemia patients.
    Khorshied MM; Said WA; Shaaban HA
    Saudi Med J; 2010 May; 31(5):582-4. PubMed ID: 20464055
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic factors of acute myeloid leukemia].
    Inokuchi K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
    Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
    Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
    Pollyea DA; Kohrt HE; Zhang B; Zehnder J; Schenkein D; Fantin V; Straley K; Vasanthakumar A; Abdel-Wahab O; Levine R; Godley LA; Medeiros BC
    Leuk Lymphoma; 2013 Feb; 54(2):408-10. PubMed ID: 22680765
    [No Abstract]   [Full Text] [Related]  

  • 10. NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation.
    Raman HS; Shanmugam V; Li J; Steensma DP; Kim AS; Luskin MR
    Leuk Lymphoma; 2021 Jul; 62(7):1790-1792. PubMed ID: 33586600
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of the IDH1 gene mutation in acute myeloid leukemia by PCR-high resolution melting analysis].
    Lin J; Qian J; Yao DM
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):484-6. PubMed ID: 22213873
    [No Abstract]   [Full Text] [Related]  

  • 12. [IDH gene mutations and acute myeloid leukemia].
    Sun C; Zhang SJ; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):273-5. PubMed ID: 23683434
    [No Abstract]   [Full Text] [Related]  

  • 13. Enasidenib for relapsed/refractory acute myeloid leukemia with IDH2 mutations: optimizing the patient experience.
    Roboz GJ
    Clin Adv Hematol Oncol; 2018 May; 16(5):322-325. PubMed ID: 29851927
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia.
    Gupta C; Kaulfuss S; Görlich K; Othman B; Chaturvedi A; Heuser M
    Ann Hematol; 2020 Jun; 99(6):1415-1417. PubMed ID: 32296913
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing.
    Andrulis M; Capper D; Luft T; Hartmann C; Zentgraf H; von Deimling A
    Leuk Res; 2010 Aug; 34(8):1091-3. PubMed ID: 20227112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDH1 inhibitor shows promising early results.
    Cancer Discov; 2015 Jan; 5(1):4. PubMed ID: 25583779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.
    Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF; Xu WR
    Clin Biochem; 2011 Jul; 44(10-11):779-83. PubMed ID: 21539821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene.
    Jeziskova I; Razga F; Toskova M; Dvorakova D; Timilsina S; Mayer J; Racil Z
    Leuk Lymphoma; 2013 Apr; 54(4):867-70. PubMed ID: 22950897
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
    Marcucci G; Haferlach T; Döhner H
    J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytological features of NPM1-mutated acute myeloid leukemia.
    Bain BJ; Heller M; Toma S; Pavlů J
    Am J Hematol; 2015 Jun; 90(6):560. PubMed ID: 25779376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.